{"gene":"ABI2","run_date":"2026-06-09T22:02:37","timeline":{"discoveries":[{"year":1995,"finding":"ABI2 (Abi-2) was identified as a protein that binds specifically to both the SH3 domain and carboxy-terminal sequences of c-Abl tyrosine kinase in vitro and in vivo; ABI2 contains proline-rich sequences critical for binding the Abl SH3 domain, and ABI2 is a substrate for c-Abl tyrosine kinase phosphorylation. Expression of an ABI2 mutant lacking the Abl SH3-binding sequences but retaining carboxyl-terminus binding activated c-Abl transforming capacity.","method":"Yeast two-hybrid screen, in vitro binding assay, in vivo co-immunoprecipitation, kinase substrate assay, mutant overexpression","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal in vitro and in vivo binding, substrate phosphorylation demonstrated, functional mutagenesis confirming domain requirements, foundational study replicated in subsequent work","pmids":["7590236"],"is_preprint":false},{"year":2000,"finding":"Abi-2 protein is concentrated in puncta throughout the cell body and processes of cultured neurons, and is present in synaptosomes and growth cone particles, consistent with a role in Abl kinase signaling at synapses and growth cones in the developing nervous system. Abi proteins from brain lysates undergo changes in apparent molecular weight and phosphorylation with increasing age.","method":"Immunofluorescence in cultured neurons, subcellular fractionation (synaptosome and growth cone particle isolation), Western blotting","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular fractionation and localization with developmental phosphorylation changes shown, single lab, two orthogonal methods","pmids":["10995551"],"is_preprint":false},{"year":2004,"finding":"Homozygous deletion of murine Abi2 causes defective secondary lens fiber cell migration and orientation in the eye, cell migration defects in the neocortex and hippocampus, abnormal dendritic spine morphology and density, and severe deficits in short- and long-term memory. Abi2 localizes to adherens junctions in the developing lens and at nascent epithelial cell adherens junctions in vitro. RNAi-mediated Abi downregulation impaired adherens junction formation and correlated with downregulation of the WAVE actin-nucleation promoting factor.","method":"Knockout mouse (homozygous deletion), RNA interference, immunolocalization, behavioral assays (memory tests), live imaging","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with multiple specific phenotypes, RNAi confirmation, localization experiments with functional consequence, multiple orthogonal methods","pmids":["15572692"],"is_preprint":false},{"year":2007,"finding":"Phosphorylation of c-Abl at serines 637 and 638 by Pak2 kinase dramatically reduces (~90%) ABI2 binding to c-Abl's PxxP motif, establishing a mechanism whereby Pak2-mediated phosphorylation of c-Abl inhibits the ABI2 SH3 domain–c-Abl PxxP interaction. This phosphorylation simultaneously increases Crk binding to c-Abl and c-Abl-mediated Crk phosphorylation.","method":"In vitro kinase assay (Pak2 phosphorylation of c-Abl fragments), binding assay, site-directed mutagenesis (S637/638/639A and 3D mutants), co-immunoprecipitation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted phosphorylation assay with mutagenesis and binding quantification, single lab but multiple orthogonal methods","pmids":["18161990"],"is_preprint":false},{"year":2012,"finding":"WAVE2-Abi2 complex regulates growth cone activity in migrating cortical neurons. Abl kinase and Cdk5 phosphorylate WAVE2 at tyrosine 150 and serine 137, regulating WAVE2-Abi2 activity, which controls the multipolar-to-bipolar transition and initiation of glia-guided radial migration. Neurons lacking proper WAVE2-Abi2 function are mispositioned in the neocortex.","method":"Time-lapse imaging (lattice assays), phosphorylation-site mutagenesis of WAVE2, in vivo cortical positioning analysis","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — time-lapse imaging with mutagenesis and in vivo positioning readout, single lab, two orthogonal methods","pmids":["22617848"],"is_preprint":false},{"year":2016,"finding":"TIS21/BTG2 inhibits ABI2-DRF (diaphanous-related formin) pathway by reducing ABI2 protein stability and DRF expression, thereby downregulating doxorubicin-induced stress fiber formation and thick vimentin networks. This occurs downstream of Nox4-derived ROS, placing ABI2 in a Nox4-ROS-ABI2-DRF signal cascade controlling linear actin nucleation.","method":"Cell-based overexpression/knockdown, super-resolution STED microscopy, Western blotting, ROS measurement","journal":"Cellular signalling","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, pathway placement inferred from expression-level changes, no direct biochemical reconstitution of ABI2-DRF interaction","pmids":["27932314"],"is_preprint":false},{"year":2023,"finding":"PIM1 kinase phosphorylates ABI2 at Ser183, increasing ABI2 protein levels and enhancing WAVE regulatory complex (WRC) formation, resulting in increased protrusive activity and cell motility. Hypoxia-induced and PIM1-induced cell protrusion was dependent on ABI2. In vivo smooth muscle invasion assays showed PIM1 overexpression increased tumor invasion depth, and PIM inhibitors reduced invasion.","method":"Unbiased proteomic screen (PIM1 substrate identification), in vitro kinase assay, phospho-site mutagenesis (Ser183), co-immunoprecipitation (WRC formation), cell protrusion assays, in vivo invasion assay, PIM inhibitor treatment","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, WRC co-IP, multiple cell-based phenotypes, in vivo validation, single lab with orthogonal methods","pmids":["37042842"],"is_preprint":false},{"year":2022,"finding":"PRR16/Largen binds to ABI2 (identified by co-immunoprecipitation/pulldown screen), and knockdown of ABI2 or overexpression of PRR16 both increase ABL1 kinase phosphorylation at Y412, suggesting ABI2 normally inhibits ABL1 kinase activity; PRR16 binding to ABI2 interferes with this inhibition to promote EMT.","method":"Co-immunoprecipitation/binding protein screen, gene silencing (siRNA), Western blotting (ABL1 Y412 phosphorylation), migration/invasion assays","journal":"Biomolecules & therapeutics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP and knockdown phenotype, no direct biochemical reconstitution of ABI2 inhibiting ABL1, single lab single method for the mechanistic claim","pmids":["35719027"],"is_preprint":false},{"year":2024,"finding":"ABI2 interacts with RAC1 (Rho GTPase) as shown by co-immunoprecipitation, and this interaction is associated with inhibition of the PI3K/Akt signaling pathway. E3 ubiquitin ligase CBLC promotes ubiquitination and proteasomal degradation of ABI2 protein.","method":"Co-immunoprecipitation, RNA-seq, siRNA knockdown, ubiquitination assay, Western blotting","journal":"Cancer cell international","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP for RAC1 interaction, ubiquitination shown but limited mechanistic follow-up, single lab","pmids":["38937761"],"is_preprint":false},{"year":2024,"finding":"ABI2 serves as a co-activator of the transcription factor HHEX, and together they upregulate SLC17A9 transcription to promote HCC cancer stem cell-like properties.","method":"Co-immunoprecipitation, reporter assay, ChIP, gene knockdown/overexpression","journal":"Journal of translational medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanistic claim based on co-IP and reporter assay without in vitro reconstitution","pmids":["38844969"],"is_preprint":false},{"year":2022,"finding":"ABI2 recruits and directly interacts with the transcription factor MEOX2, which then binds to KLF4 and NANOG promoter regions to activate their transcription, thereby maintaining HCC cancer stem cell properties.","method":"Co-immunoprecipitation, ChIP (MEOX2 binding to KLF4/NANOG promoters), gene overexpression/knockdown, xenograft assay","journal":"Liver international","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, Co-IP with ChIP, mechanistic chain is plausible but reconstitution not performed","pmids":["36017822"],"is_preprint":false},{"year":2020,"finding":"EBV-miR-BART13-3p directly targets the ABI2 3'UTR to downregulate ABI2 expression, and ABI2 silencing alone recapitulates increased NPC cell migration/invasion and EMT via activation of c-JUN/SLUG signaling; reconstitution of ABI2 reverses this phenotype.","method":"Luciferase 3'UTR reporter assay (direct miRNA targeting), siRNA silencing, overexpression rescue, migration/invasion assays, in vivo xenograft","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3'UTR targeting validated by reporter assay, siRNA plus rescue experiment, two orthogonal methods, single lab","pmids":["31907338"],"is_preprint":false}],"current_model":"ABI2 (Abl-interactor 2) is an SH3 domain-containing adaptor protein that binds c-Abl tyrosine kinase (via SH3–PxxP interaction) and serves as its substrate; it is an integral component of the WAVE regulatory complex (WRC) that drives Arp2/3-dependent actin polymerization and lamellipodia formation downstream of Rac1, with its activity regulated by phosphorylation (by c-Abl, Pak2, and PIM1 kinase at Ser183) and by ubiquitin-mediated degradation (via E3 ligase CBLC); loss of Abi2 in mice causes defective cell migration, abnormal dendritic spine morphology, adherens junction defects through WAVE downregulation, and cognitive impairment, establishing ABI2 as a critical regulator of cytoskeletal dynamics at adherens junctions and dendritic spines."},"narrative":{"mechanistic_narrative":"ABI2 (Abl-interactor 2) is an SH3/proline-rich adaptor protein that couples c-Abl tyrosine kinase signaling to actin cytoskeletal remodeling, originally defined by its specific binding to the SH3 domain and C-terminus of c-Abl through its proline-rich sequences, where it also serves as a c-Abl phosphorylation substrate [PMID:7590236]. ABI2 functions as a core component of the WAVE regulatory complex (WRC), and its proper function drives WAVE2-dependent actin nucleation and protrusive activity that governs growth-cone behavior and the multipolar-to-bipolar transition during glia-guided radial neuronal migration [PMID:22617848]. Genetic loss of Abi2 in mice produces defective cell migration in the lens, neocortex and hippocampus, abnormal dendritic spine morphology, adherens-junction defects accompanied by downregulation of the WAVE nucleation-promoting factor, and severe memory deficits, establishing ABI2 as a critical regulator of cytoskeletal dynamics at adherens junctions and synaptic structures [PMID:15572692]. ABI2 also localizes in puncta within neuronal cell bodies, processes, synaptosomes and growth-cone particles, consistent with its role in Abl signaling at developing synapses [PMID:10995551]. ABI2 activity is set by phosphorylation: PIM1 phosphorylates ABI2 at Ser183 to stabilize the protein and enhance WRC assembly, increasing motility and invasion [PMID:37042842], while Pak2-mediated phosphorylation of c-Abl disrupts the ABI2 SH3–c-Abl PxxP interaction [PMID:18161990].","teleology":[{"year":1995,"claim":"Established ABI2's foundational identity as a direct c-Abl-binding adaptor and substrate, defining the SH3–proline-rich interaction module that anchors all later signaling models.","evidence":"Yeast two-hybrid, in vitro and in vivo binding, kinase substrate assay, and functional mutagenesis of Abl SH3-binding sequences","pmids":["7590236"],"confidence":"High","gaps":["Did not define a cellular cytoskeletal output of the interaction","Structural basis of dual SH3/C-terminal binding not resolved"]},{"year":2000,"claim":"Placed ABI2 protein at synapses and growth cones, localizing Abl-pathway adaptor function to specific neuronal compartments in the developing nervous system.","evidence":"Immunofluorescence, synaptosome/growth-cone fractionation and Western blotting of brain lysates","pmids":["10995551"],"confidence":"Medium","gaps":["Functional consequence of synaptic localization not tested","Identity of the developmentally regulated modifying kinase unknown"]},{"year":2004,"claim":"Demonstrated through knockout that ABI2 is required in vivo for cell migration, dendritic spine morphology, adherens-junction integrity and memory, linking it mechanistically to WAVE-dependent actin nucleation.","evidence":"Homozygous Abi2 knockout mouse with behavioral assays, RNAi, and adherens-junction immunolocalization showing WAVE downregulation","pmids":["15572692"],"confidence":"High","gaps":["Did not resolve how ABI2 loss reduces WAVE protein levels","Cell-type-specific contributions to the memory phenotype not dissected"]},{"year":2007,"claim":"Revealed that the ABI2–c-Abl interaction is switchable, showing Pak2 phosphorylation of c-Abl disrupts ABI2 binding while favoring Crk, establishing competitive regulation of c-Abl partner choice.","evidence":"In vitro Pak2 kinase assay on c-Abl fragments with phospho-mimetic mutagenesis and binding/co-IP quantification","pmids":["18161990"],"confidence":"High","gaps":["Cellular contexts where this switch operates not defined","Downstream actin consequence of ABI2 displacement not measured"]},{"year":2012,"claim":"Connected the WAVE2-ABI2 complex to a defined developmental step, showing Abl/Cdk5 phosphorylation of WAVE2 controls growth-cone activity and the multipolar-to-bipolar transition during radial migration.","evidence":"Time-lapse lattice imaging, WAVE2 phospho-site mutagenesis, and in vivo cortical positioning analysis","pmids":["22617848"],"confidence":"Medium","gaps":["Direct ABI2 phospho-regulation in this step not isolated","Single-lab phenotype"]},{"year":2023,"claim":"Identified PIM1 phosphorylation of ABI2 at Ser183 as a stabilizing modification that promotes WRC assembly and motility, providing a kinase input that tunes ABI2 abundance and protrusive output.","evidence":"Unbiased PIM1 substrate proteomics, in vitro kinase assay, Ser183 mutagenesis, WRC co-IP, protrusion and in vivo invasion assays with PIM inhibitors","pmids":["37042842"],"confidence":"High","gaps":["Mechanism by which Ser183 phosphorylation stabilizes the protein unknown","Relationship to CBLC-mediated degradation not tested"]},{"year":2016,"claim":"Proposed ABI2 in a Nox4-ROS-ABI2-DRF cascade controlling linear actin nucleation, with TIS21/BTG2 reducing ABI2 stability.","evidence":"Cell-based overexpression/knockdown, STED microscopy, ROS measurement and Western blotting","pmids":["27932314"],"confidence":"Low","gaps":["No direct biochemical reconstitution of an ABI2-DRF interaction","Pathway placement inferred only from expression-level changes"]},{"year":2022,"claim":"Posited that ABI2 normally restrains ABL1 kinase activity and that PRR16/Largen binding relieves this inhibition to promote EMT.","evidence":"Co-IP/binding screen, siRNA silencing, ABL1 Y412 phospho-Western and migration/invasion assays","pmids":["35719027"],"confidence":"Low","gaps":["No reconstitution of ABI2 inhibiting ABL1","Single Co-IP for the PRR16 interaction"]},{"year":2022,"claim":"Reported a non-cytoskeletal nuclear role in which ABI2 recruits MEOX2 to activate KLF4/NANOG transcription and maintain HCC cancer stem-cell properties.","evidence":"Co-IP, ChIP of MEOX2 at KLF4/NANOG promoters, knockdown/overexpression and xenograft","pmids":["36017822"],"confidence":"Low","gaps":["No reconstitution of the ABI2-MEOX2 transcriptional complex","Mechanism of ABI2 nuclear function unresolved"]},{"year":2024,"claim":"Extended the transcriptional-coactivator model, reporting ABI2 partnering with HHEX to upregulate SLC17A9 in HCC stem-like cells.","evidence":"Co-IP, reporter assay, ChIP and gene perturbation","pmids":["38844969"],"confidence":"Low","gaps":["No in vitro reconstitution","Relationship to cytoskeletal ABI2 functions unclear"]},{"year":2024,"claim":"Described ABI2 interaction with RAC1 linked to PI3K/Akt suppression and identified CBLC as an E3 ligase driving ABI2 proteasomal degradation, adding a turnover input to ABI2 regulation.","evidence":"Co-IP, RNA-seq, siRNA, ubiquitination assay and Western blotting","pmids":["38937761"],"confidence":"Low","gaps":["Single Co-IP for the RAC1 interaction","Mechanism linking ABI2 to PI3K/Akt not established"]},{"year":2020,"claim":"Showed ABI2 is a direct target of EBV-miR-BART13-3p and that its loss drives NPC migration/EMT via c-JUN/SLUG, positioning ABI2 as a migration suppressor in this context.","evidence":"Luciferase 3'UTR reporter, siRNA plus overexpression rescue, migration/invasion assays and xenograft","pmids":["31907338"],"confidence":"Medium","gaps":["Molecular link from ABI2 to c-JUN/SLUG not defined","Cytoskeletal versus transcriptional basis of suppression not separated"]},{"year":null,"claim":"How ABI2's well-established WRC/actin-regulatory function mechanistically relates to its reported nuclear transcriptional-coactivator roles, and how the competing kinase (PIM1, Pak2, Abl, Cdk5) and degradation (CBLC) inputs are integrated, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of ABI2 within the WRC","Nuclear and cytoplasmic functions not reconciled in one system","Integration of opposing stabilizing and degradative signals undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2,4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4]}],"complexes":["WAVE regulatory complex (WRC)"],"partners":["ABL1","WAVE2","RAC1","PIM1","CBLC","PRR16","MEOX2","HHEX"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NYB9","full_name":"Abl interactor 2","aliases":["Abelson interactor 2","Abi-2","Abl-binding protein 3","AblBP3","Arg-binding protein 1","ArgBP1"],"length_aa":513,"mass_kda":55.7,"function":"Regulator of actin cytoskeleton dynamics underlying cell motility and adhesion. Functions as a component of the WAVE complex, which activates actin nucleating machinery Arp2/3 to drive lamellipodia formation (PubMed:21107423). Acts as a regulator and substrate of nonreceptor tyrosine kinases ABL1 and ABL2 involved in processes linked to cell growth and differentiation. Positively regulates ABL1-mediated phosphorylation of ENAH, which is required for proper polymerization of nucleated actin filaments at the leading edge (PubMed:10498863, PubMed:7590236, PubMed:8649853). Contributes to the regulation of actin assembly at the tips of neuron projections. In particular, controls dendritic spine morphogenesis and may promote dendritic spine specification toward large mushroom-type spines known as repositories of memory in the brain (By similarity). In hippocampal neurons, may mediate actin-dependent BDNF-NTRK2 early endocytic trafficking that triggers dendrite outgrowth (By similarity). Participates in ocular lens morphogenesis, likely by regulating lamellipodia-driven adherens junction formation at the epithelial cell-secondary lens fiber interface (By similarity). Also required for nascent adherens junction assembly in epithelial cells (PubMed:15572692)","subcellular_location":"Cell projection, lamellipodium; Cell projection, filopodium; Cytoplasm, cytoskeleton; Cell junction, adherens junction","url":"https://www.uniprot.org/uniprotkb/Q9NYB9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABI2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTB","stoichiometry":0.2},{"gene":"ACTG1","stoichiometry":0.2},{"gene":"BAIAP2","stoichiometry":0.2},{"gene":"CSNK1G3","stoichiometry":0.2},{"gene":"NCKAP1","stoichiometry":0.2},{"gene":"WASF1","stoichiometry":0.2},{"gene":"WASF2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ABI2","total_profiled":1310},"omim":[{"mim_id":"607270","title":"ACTIVATOR OF TRANSCRIPTION AND DEVELOPMENTAL REGULATOR AUTS2; AUTS2","url":"https://www.omim.org/entry/607270"},{"mim_id":"606442","title":"ABL INTERACTOR 2; ABI2","url":"https://www.omim.org/entry/606442"},{"mim_id":"605035","title":"WASP PROTEIN FAMILY, MEMBER 1; WASF1","url":"https://www.omim.org/entry/605035"},{"mim_id":"602048","title":"RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1","url":"https://www.omim.org/entry/602048"},{"mim_id":"600508","title":"NCK ADAPTOR PROTEIN 1; NCK1","url":"https://www.omim.org/entry/600508"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ABI2"},"hgnc":{"alias_symbol":["ABI-2","AIP-1","ABI2B","AblBP3","argBPIA","SSH3BP2"],"prev_symbol":[]},"alphafold":{"accession":"Q9NYB9","domains":[{"cath_id":"2.30.30.40","chopping":"455-508","consensus_level":"high","plddt":93.9233,"start":455,"end":508},{"cath_id":"1.20.58","chopping":"2-112","consensus_level":"high","plddt":97.7346,"start":2,"end":112}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYB9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYB9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYB9-F1-predicted_aligned_error_v6.png","plddt_mean":65.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABI2","jax_strain_url":"https://www.jax.org/strain/search?query=ABI2"},"sequence":{"accession":"Q9NYB9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NYB9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NYB9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYB9"}},"corpus_meta":[{"pmid":"11208021","id":"PMC_11208021","title":"The ABI1 and ABI2 protein phosphatases 2C act in a negative feedback regulatory loop of the abscisic acid signalling pathway.","date":"2001","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11208021","citation_count":449,"is_preprint":false},{"pmid":"11701885","id":"PMC_11701885","title":"Abscisic acid activation of plasma membrane Ca(2+) channels in guard cells requires cytosolic NAD(P)H and is differentially disrupted upstream and downstream of reactive oxygen species production in abi1-1 and abi2-1 protein phosphatase 2C mutants.","date":"2001","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/11701885","citation_count":382,"is_preprint":false},{"pmid":"15195070","id":"PMC_15195070","title":"Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix.","date":"2004","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/15195070","citation_count":317,"is_preprint":false},{"pmid":"14504388","id":"PMC_14504388","title":"A novel domain in the protein kinase SOS2 mediates interaction with the protein phosphatase 2C ABI2.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14504388","citation_count":272,"is_preprint":false},{"pmid":"7590236","id":"PMC_7590236","title":"Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7590236","citation_count":248,"is_preprint":false},{"pmid":"29275167","id":"PMC_29275167","title":"Abscisic Acid Signaling Inhibits Brassinosteroid Signaling through Dampening the Dephosphorylation of BIN2 by ABI1 and ABI2.","date":"2017","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/29275167","citation_count":135,"is_preprint":false},{"pmid":"11882947","id":"PMC_11882947","title":"The sensitivity of ABI2 to hydrogen peroxide links the abscisic acid-response regulator to redox signalling.","date":"2001","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/11882947","citation_count":133,"is_preprint":false},{"pmid":"15572692","id":"PMC_15572692","title":"ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15572692","citation_count":123,"is_preprint":false},{"pmid":"10995551","id":"PMC_10995551","title":"Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system.","date":"2000","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/10995551","citation_count":63,"is_preprint":false},{"pmid":"19414486","id":"PMC_19414486","title":"AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19414486","citation_count":49,"is_preprint":false},{"pmid":"36017822","id":"PMC_36017822","title":"ABI2-mediated MEOX2/KLF4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence.","date":"2022","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/36017822","citation_count":33,"is_preprint":false},{"pmid":"12011975","id":"PMC_12011975","title":"In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review).","date":"2002","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12011975","citation_count":31,"is_preprint":false},{"pmid":"31907338","id":"PMC_31907338","title":"Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31907338","citation_count":24,"is_preprint":false},{"pmid":"33811744","id":"PMC_33811744","title":"TMK4 receptor kinase negatively modulates ABA signaling by phosphorylating ABI2 and enhancing its activity.","date":"2021","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/33811744","citation_count":19,"is_preprint":false},{"pmid":"20351174","id":"PMC_20351174","title":"skn-1-Dependent and -independent regulation of aip-1 expression following metabolic stress in Caenorhabditis elegans.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20351174","citation_count":19,"is_preprint":false},{"pmid":"22617848","id":"PMC_22617848","title":"WAVE2-Abi2 complex controls growth cone activity and regulates the multipolar-bipolar transition as well as the initiation of glia-guided migration.","date":"2012","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22617848","citation_count":17,"is_preprint":false},{"pmid":"18161990","id":"PMC_18161990","title":"Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18161990","citation_count":15,"is_preprint":false},{"pmid":"28174577","id":"PMC_28174577","title":"A Novel RNA-Binding Protein Involves ABA Signaling by Post-transcriptionally Repressing ABI2.","date":"2017","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/28174577","citation_count":13,"is_preprint":false},{"pmid":"37042842","id":"PMC_37042842","title":"PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37042842","citation_count":12,"is_preprint":false},{"pmid":"35719027","id":"PMC_35719027","title":"PRR16/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 Kinase.","date":"2022","source":"Biomolecules & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35719027","citation_count":10,"is_preprint":false},{"pmid":"32496656","id":"PMC_32496656","title":"Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.","date":"2020","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32496656","citation_count":6,"is_preprint":false},{"pmid":"27932314","id":"PMC_27932314","title":"TIS21/BTG2 inhibits doxorubicin-induced stress fiber-vimentin networks via Nox4-ROS-ABI2-DRF-linked signal cascade.","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27932314","citation_count":6,"is_preprint":false},{"pmid":"35031905","id":"PMC_35031905","title":"Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis.","date":"2022","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35031905","citation_count":5,"is_preprint":false},{"pmid":"32266037","id":"PMC_32266037","title":"miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2.","date":"2020","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32266037","citation_count":5,"is_preprint":false},{"pmid":"38844969","id":"PMC_38844969","title":"The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38844969","citation_count":4,"is_preprint":false},{"pmid":"38937761","id":"PMC_38937761","title":"Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38937761","citation_count":3,"is_preprint":false},{"pmid":"40811817","id":"PMC_40811817","title":"Ethylene antagonizes ABA responses in stomatal movement and seed germination by upregulating ABI1 and ABI2 at both the transcript and protein levels.","date":"2025","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40811817","citation_count":2,"is_preprint":false},{"pmid":"39843146","id":"PMC_39843146","title":"The role of ABI2 in modulating nuclear proteins: Therapeutic implications for NUP54 and NUP153 in TNBC.","date":"2025","source":"Advances in protein chemistry and structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/39843146","citation_count":2,"is_preprint":false},{"pmid":"23828391","id":"PMC_23828391","title":"Age and dark rearing bidirectionally regulate the level and laminar pattern of expression of Abelson interacting protein 2 (Abi-2): a novel candidate visual cortical plasticity gene.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/23828391","citation_count":1,"is_preprint":false},{"pmid":"40475134","id":"PMC_40475134","title":"Missense ABI2 variants linked to a neurodevelopmental disorder with intellectual disability, epilepsy, hypoplasia of the corpus callosum, and white matter abnormalities.","date":"2025","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40475134","citation_count":0,"is_preprint":false},{"pmid":"42090565","id":"PMC_42090565","title":"StWRKY46 promotes stomatal closure and enhances potato drought tolerance by mediating the PYL1-ABI2-OST1/SnRK2.5/SnRK2.6 pathway.","date":"2026","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/42090565","citation_count":0,"is_preprint":false},{"pmid":"41366287","id":"PMC_41366287","title":"Arsenic Sulfide Induces Apoptosis in Myelodysplastic Neoplasm Cells Through the Suppression of ABI2.","date":"2025","source":"Biological procedures online","url":"https://pubmed.ncbi.nlm.nih.gov/41366287","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.19.25327541","title":"Missense<i>ABI2</i>variants linked to a neurodevelopmental disorder with intellectual disability, epilepsy, hypoplasia of the corpus callosum, and white matter abnormalities","date":"2025-05-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.19.25327541","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.30.601407","title":"Human Accelerated Regions regulate gene networks implicated in apical-to-basal neural progenitor fate transitions","date":"2024-07-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.30.601407","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17956,"output_tokens":3273,"usd":0.051481,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10748,"output_tokens":3988,"usd":0.07672,"stage2_stop_reason":"end_turn"},"total_usd":0.128201,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"ABI2 (Abi-2) was identified as a protein that binds specifically to both the SH3 domain and carboxy-terminal sequences of c-Abl tyrosine kinase in vitro and in vivo; ABI2 contains proline-rich sequences critical for binding the Abl SH3 domain, and ABI2 is a substrate for c-Abl tyrosine kinase phosphorylation. Expression of an ABI2 mutant lacking the Abl SH3-binding sequences but retaining carboxyl-terminus binding activated c-Abl transforming capacity.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, in vivo co-immunoprecipitation, kinase substrate assay, mutant overexpression\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal in vitro and in vivo binding, substrate phosphorylation demonstrated, functional mutagenesis confirming domain requirements, foundational study replicated in subsequent work\",\n      \"pmids\": [\"7590236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Abi-2 protein is concentrated in puncta throughout the cell body and processes of cultured neurons, and is present in synaptosomes and growth cone particles, consistent with a role in Abl kinase signaling at synapses and growth cones in the developing nervous system. Abi proteins from brain lysates undergo changes in apparent molecular weight and phosphorylation with increasing age.\",\n      \"method\": \"Immunofluorescence in cultured neurons, subcellular fractionation (synaptosome and growth cone particle isolation), Western blotting\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular fractionation and localization with developmental phosphorylation changes shown, single lab, two orthogonal methods\",\n      \"pmids\": [\"10995551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Homozygous deletion of murine Abi2 causes defective secondary lens fiber cell migration and orientation in the eye, cell migration defects in the neocortex and hippocampus, abnormal dendritic spine morphology and density, and severe deficits in short- and long-term memory. Abi2 localizes to adherens junctions in the developing lens and at nascent epithelial cell adherens junctions in vitro. RNAi-mediated Abi downregulation impaired adherens junction formation and correlated with downregulation of the WAVE actin-nucleation promoting factor.\",\n      \"method\": \"Knockout mouse (homozygous deletion), RNA interference, immunolocalization, behavioral assays (memory tests), live imaging\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with multiple specific phenotypes, RNAi confirmation, localization experiments with functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"15572692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Phosphorylation of c-Abl at serines 637 and 638 by Pak2 kinase dramatically reduces (~90%) ABI2 binding to c-Abl's PxxP motif, establishing a mechanism whereby Pak2-mediated phosphorylation of c-Abl inhibits the ABI2 SH3 domain–c-Abl PxxP interaction. This phosphorylation simultaneously increases Crk binding to c-Abl and c-Abl-mediated Crk phosphorylation.\",\n      \"method\": \"In vitro kinase assay (Pak2 phosphorylation of c-Abl fragments), binding assay, site-directed mutagenesis (S637/638/639A and 3D mutants), co-immunoprecipitation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted phosphorylation assay with mutagenesis and binding quantification, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"18161990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"WAVE2-Abi2 complex regulates growth cone activity in migrating cortical neurons. Abl kinase and Cdk5 phosphorylate WAVE2 at tyrosine 150 and serine 137, regulating WAVE2-Abi2 activity, which controls the multipolar-to-bipolar transition and initiation of glia-guided radial migration. Neurons lacking proper WAVE2-Abi2 function are mispositioned in the neocortex.\",\n      \"method\": \"Time-lapse imaging (lattice assays), phosphorylation-site mutagenesis of WAVE2, in vivo cortical positioning analysis\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — time-lapse imaging with mutagenesis and in vivo positioning readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"22617848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TIS21/BTG2 inhibits ABI2-DRF (diaphanous-related formin) pathway by reducing ABI2 protein stability and DRF expression, thereby downregulating doxorubicin-induced stress fiber formation and thick vimentin networks. This occurs downstream of Nox4-derived ROS, placing ABI2 in a Nox4-ROS-ABI2-DRF signal cascade controlling linear actin nucleation.\",\n      \"method\": \"Cell-based overexpression/knockdown, super-resolution STED microscopy, Western blotting, ROS measurement\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, pathway placement inferred from expression-level changes, no direct biochemical reconstitution of ABI2-DRF interaction\",\n      \"pmids\": [\"27932314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PIM1 kinase phosphorylates ABI2 at Ser183, increasing ABI2 protein levels and enhancing WAVE regulatory complex (WRC) formation, resulting in increased protrusive activity and cell motility. Hypoxia-induced and PIM1-induced cell protrusion was dependent on ABI2. In vivo smooth muscle invasion assays showed PIM1 overexpression increased tumor invasion depth, and PIM inhibitors reduced invasion.\",\n      \"method\": \"Unbiased proteomic screen (PIM1 substrate identification), in vitro kinase assay, phospho-site mutagenesis (Ser183), co-immunoprecipitation (WRC formation), cell protrusion assays, in vivo invasion assay, PIM inhibitor treatment\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, WRC co-IP, multiple cell-based phenotypes, in vivo validation, single lab with orthogonal methods\",\n      \"pmids\": [\"37042842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PRR16/Largen binds to ABI2 (identified by co-immunoprecipitation/pulldown screen), and knockdown of ABI2 or overexpression of PRR16 both increase ABL1 kinase phosphorylation at Y412, suggesting ABI2 normally inhibits ABL1 kinase activity; PRR16 binding to ABI2 interferes with this inhibition to promote EMT.\",\n      \"method\": \"Co-immunoprecipitation/binding protein screen, gene silencing (siRNA), Western blotting (ABL1 Y412 phosphorylation), migration/invasion assays\",\n      \"journal\": \"Biomolecules & therapeutics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP and knockdown phenotype, no direct biochemical reconstitution of ABI2 inhibiting ABL1, single lab single method for the mechanistic claim\",\n      \"pmids\": [\"35719027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ABI2 interacts with RAC1 (Rho GTPase) as shown by co-immunoprecipitation, and this interaction is associated with inhibition of the PI3K/Akt signaling pathway. E3 ubiquitin ligase CBLC promotes ubiquitination and proteasomal degradation of ABI2 protein.\",\n      \"method\": \"Co-immunoprecipitation, RNA-seq, siRNA knockdown, ubiquitination assay, Western blotting\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP for RAC1 interaction, ubiquitination shown but limited mechanistic follow-up, single lab\",\n      \"pmids\": [\"38937761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ABI2 serves as a co-activator of the transcription factor HHEX, and together they upregulate SLC17A9 transcription to promote HCC cancer stem cell-like properties.\",\n      \"method\": \"Co-immunoprecipitation, reporter assay, ChIP, gene knockdown/overexpression\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanistic claim based on co-IP and reporter assay without in vitro reconstitution\",\n      \"pmids\": [\"38844969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ABI2 recruits and directly interacts with the transcription factor MEOX2, which then binds to KLF4 and NANOG promoter regions to activate their transcription, thereby maintaining HCC cancer stem cell properties.\",\n      \"method\": \"Co-immunoprecipitation, ChIP (MEOX2 binding to KLF4/NANOG promoters), gene overexpression/knockdown, xenograft assay\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, Co-IP with ChIP, mechanistic chain is plausible but reconstitution not performed\",\n      \"pmids\": [\"36017822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EBV-miR-BART13-3p directly targets the ABI2 3'UTR to downregulate ABI2 expression, and ABI2 silencing alone recapitulates increased NPC cell migration/invasion and EMT via activation of c-JUN/SLUG signaling; reconstitution of ABI2 reverses this phenotype.\",\n      \"method\": \"Luciferase 3'UTR reporter assay (direct miRNA targeting), siRNA silencing, overexpression rescue, migration/invasion assays, in vivo xenograft\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3'UTR targeting validated by reporter assay, siRNA plus rescue experiment, two orthogonal methods, single lab\",\n      \"pmids\": [\"31907338\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABI2 (Abl-interactor 2) is an SH3 domain-containing adaptor protein that binds c-Abl tyrosine kinase (via SH3–PxxP interaction) and serves as its substrate; it is an integral component of the WAVE regulatory complex (WRC) that drives Arp2/3-dependent actin polymerization and lamellipodia formation downstream of Rac1, with its activity regulated by phosphorylation (by c-Abl, Pak2, and PIM1 kinase at Ser183) and by ubiquitin-mediated degradation (via E3 ligase CBLC); loss of Abi2 in mice causes defective cell migration, abnormal dendritic spine morphology, adherens junction defects through WAVE downregulation, and cognitive impairment, establishing ABI2 as a critical regulator of cytoskeletal dynamics at adherens junctions and dendritic spines.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ABI2 (Abl-interactor 2) is an SH3/proline-rich adaptor protein that couples c-Abl tyrosine kinase signaling to actin cytoskeletal remodeling, originally defined by its specific binding to the SH3 domain and C-terminus of c-Abl through its proline-rich sequences, where it also serves as a c-Abl phosphorylation substrate [#0]. ABI2 functions as a core component of the WAVE regulatory complex (WRC), and its proper function drives WAVE2-dependent actin nucleation and protrusive activity that governs growth-cone behavior and the multipolar-to-bipolar transition during glia-guided radial neuronal migration [#4]. Genetic loss of Abi2 in mice produces defective cell migration in the lens, neocortex and hippocampus, abnormal dendritic spine morphology, adherens-junction defects accompanied by downregulation of the WAVE nucleation-promoting factor, and severe memory deficits, establishing ABI2 as a critical regulator of cytoskeletal dynamics at adherens junctions and synaptic structures [#2]. ABI2 also localizes in puncta within neuronal cell bodies, processes, synaptosomes and growth-cone particles, consistent with its role in Abl signaling at developing synapses [#1]. ABI2 activity is set by phosphorylation: PIM1 phosphorylates ABI2 at Ser183 to stabilize the protein and enhance WRC assembly, increasing motility and invasion [#6], while Pak2-mediated phosphorylation of c-Abl disrupts the ABI2 SH3\\u2013c-Abl PxxP interaction [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established ABI2's foundational identity as a direct c-Abl-binding adaptor and substrate, defining the SH3\\u2013proline-rich interaction module that anchors all later signaling models.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro and in vivo binding, kinase substrate assay, and functional mutagenesis of Abl SH3-binding sequences\",\n      \"pmids\": [\"7590236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define a cellular cytoskeletal output of the interaction\", \"Structural basis of dual SH3/C-terminal binding not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Placed ABI2 protein at synapses and growth cones, localizing Abl-pathway adaptor function to specific neuronal compartments in the developing nervous system.\",\n      \"evidence\": \"Immunofluorescence, synaptosome/growth-cone fractionation and Western blotting of brain lysates\",\n      \"pmids\": [\"10995551\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of synaptic localization not tested\", \"Identity of the developmentally regulated modifying kinase unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated through knockout that ABI2 is required in vivo for cell migration, dendritic spine morphology, adherens-junction integrity and memory, linking it mechanistically to WAVE-dependent actin nucleation.\",\n      \"evidence\": \"Homozygous Abi2 knockout mouse with behavioral assays, RNAi, and adherens-junction immunolocalization showing WAVE downregulation\",\n      \"pmids\": [\"15572692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how ABI2 loss reduces WAVE protein levels\", \"Cell-type-specific contributions to the memory phenotype not dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed that the ABI2\\u2013c-Abl interaction is switchable, showing Pak2 phosphorylation of c-Abl disrupts ABI2 binding while favoring Crk, establishing competitive regulation of c-Abl partner choice.\",\n      \"evidence\": \"In vitro Pak2 kinase assay on c-Abl fragments with phospho-mimetic mutagenesis and binding/co-IP quantification\",\n      \"pmids\": [\"18161990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular contexts where this switch operates not defined\", \"Downstream actin consequence of ABI2 displacement not measured\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected the WAVE2-ABI2 complex to a defined developmental step, showing Abl/Cdk5 phosphorylation of WAVE2 controls growth-cone activity and the multipolar-to-bipolar transition during radial migration.\",\n      \"evidence\": \"Time-lapse lattice imaging, WAVE2 phospho-site mutagenesis, and in vivo cortical positioning analysis\",\n      \"pmids\": [\"22617848\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ABI2 phospho-regulation in this step not isolated\", \"Single-lab phenotype\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified PIM1 phosphorylation of ABI2 at Ser183 as a stabilizing modification that promotes WRC assembly and motility, providing a kinase input that tunes ABI2 abundance and protrusive output.\",\n      \"evidence\": \"Unbiased PIM1 substrate proteomics, in vitro kinase assay, Ser183 mutagenesis, WRC co-IP, protrusion and in vivo invasion assays with PIM inhibitors\",\n      \"pmids\": [\"37042842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which Ser183 phosphorylation stabilizes the protein unknown\", \"Relationship to CBLC-mediated degradation not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Proposed ABI2 in a Nox4-ROS-ABI2-DRF cascade controlling linear actin nucleation, with TIS21/BTG2 reducing ABI2 stability.\",\n      \"evidence\": \"Cell-based overexpression/knockdown, STED microscopy, ROS measurement and Western blotting\",\n      \"pmids\": [\"27932314\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical reconstitution of an ABI2-DRF interaction\", \"Pathway placement inferred only from expression-level changes\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Posited that ABI2 normally restrains ABL1 kinase activity and that PRR16/Largen binding relieves this inhibition to promote EMT.\",\n      \"evidence\": \"Co-IP/binding screen, siRNA silencing, ABL1 Y412 phospho-Western and migration/invasion assays\",\n      \"pmids\": [\"35719027\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstitution of ABI2 inhibiting ABL1\", \"Single Co-IP for the PRR16 interaction\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Reported a non-cytoskeletal nuclear role in which ABI2 recruits MEOX2 to activate KLF4/NANOG transcription and maintain HCC cancer stem-cell properties.\",\n      \"evidence\": \"Co-IP, ChIP of MEOX2 at KLF4/NANOG promoters, knockdown/overexpression and xenograft\",\n      \"pmids\": [\"36017822\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstitution of the ABI2-MEOX2 transcriptional complex\", \"Mechanism of ABI2 nuclear function unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended the transcriptional-coactivator model, reporting ABI2 partnering with HHEX to upregulate SLC17A9 in HCC stem-like cells.\",\n      \"evidence\": \"Co-IP, reporter assay, ChIP and gene perturbation\",\n      \"pmids\": [\"38844969\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vitro reconstitution\", \"Relationship to cytoskeletal ABI2 functions unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Described ABI2 interaction with RAC1 linked to PI3K/Akt suppression and identified CBLC as an E3 ligase driving ABI2 proteasomal degradation, adding a turnover input to ABI2 regulation.\",\n      \"evidence\": \"Co-IP, RNA-seq, siRNA, ubiquitination assay and Western blotting\",\n      \"pmids\": [\"38937761\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single Co-IP for the RAC1 interaction\", \"Mechanism linking ABI2 to PI3K/Akt not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed ABI2 is a direct target of EBV-miR-BART13-3p and that its loss drives NPC migration/EMT via c-JUN/SLUG, positioning ABI2 as a migration suppressor in this context.\",\n      \"evidence\": \"Luciferase 3'UTR reporter, siRNA plus overexpression rescue, migration/invasion assays and xenograft\",\n      \"pmids\": [\"31907338\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link from ABI2 to c-JUN/SLUG not defined\", \"Cytoskeletal versus transcriptional basis of suppression not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ABI2's well-established WRC/actin-regulatory function mechanistically relates to its reported nuclear transcriptional-coactivator roles, and how the competing kinase (PIM1, Pak2, Abl, Cdk5) and degradation (CBLC) inputs are integrated, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of ABI2 within the WRC\", \"Nuclear and cytoplasmic functions not reconciled in one system\", \"Integration of opposing stabilizing and degradative signals undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0030027\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"complexes\": [\n      \"WAVE regulatory complex (WRC)\"\n    ],\n    \"partners\": [\n      \"ABL1\",\n      \"WAVE2\",\n      \"RAC1\",\n      \"PIM1\",\n      \"CBLC\",\n      \"PRR16\",\n      \"MEOX2\",\n      \"HHEX\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}